Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 31.10.2024Fresenius Kabi s.r.o. (FRK-CZ-3)58746Ciprofloxacin Kabi 400 mg/200 ml (sol inf 10x200 ml/400 mg (fľ.PE))31.10.2024O
 31.10.2024Fresenius Kabi s.r.o. (FRK-CZ-3)33623Glucose Fresenius Kabi 5 % (sol inf 10x500 ml (fľ.LDPE - KabiPac))31.10.2024O
 31.10.2024Fresenius Kabi s.r.o. (FRK-CZ-3)47125Sodium chloride Fresenius Kabi 0,9 % (sol inf 10x1000 ml (vak Freeflex))31.10.2024O
 31.10.2024Fresenius Kabi s.r.o. (FRK-CZ-3)45952Ceftriaxon Kabi 1 g (plo ijf 10x1 g (liek.skl.))31.10.2024O
 31.10.2024Fresenius Kabi s.r.o. (FRK-CZ-3)7393DNorepinephrine Kabi 1 mg/ml (con inf 10x10 ml (amp.skl.))31.10.2024O
 30.10.2024Accord Healthcare S.L.U (ACC-ES)2652EPlerixafor Accord 20 mg/ml injekčný roztok (sol inj 1x1,2 ml/24 mg (liek.inj.skl.))20.8.2024U
 30.10.2024Accord Healthcare S.L.U (ACC-ES)3862EDabigatran etexilate Accord 150 mg tvrdé kapsuly (cps dur 60x1x150 mg (blis.OPA/Al/DES PE-PET/Al/PE - jednotl.d.))30.10.2024R
 30.10.2024Accord Healthcare S.L.U (ACC-ES)3852EDabigatran etexilate Accord 110 mg tvrdé kapsuly (cps dur 60x1x110 mg (blis.OPA/Al/DES PE-PET/Al/PE - jednotl.d.))30.10.2024R
 30.10.2024Accord Healthcare S.L.U (ACC-ES)1559ADocetaxel Accord 20 mg/1 ml infúzny koncentrát (con inf 1x1 ml/20 mg (liek.inj.skl.))30.10.2024R
 30.10.2024Accord Healthcare S.L.U (ACC-ES)1560ADocetaxel Accord 80 mg/4 ml infúzny koncentrát (con inf 1x4 ml/80 mg (liek.inj.skl.))30.10.2024R
 30.10.2024Accord Healthcare Polska Sp. z o.o. (AOK)5805EPazopanib Accord 200 mg filmom obalené tablety (tbl flm 90x200 mg (blis.PVC/PE/PVDC/Al))1.10.2024U
 30.10.2024Accord Healthcare Polska Sp. z o.o. (AOK)5800EPazopanib Accord 400 mg filmom obalené tablety (tbl flm 30x400 mg (fľ.HDPE))1.10.2024U
 29.10.2024Haleon Czech Republic s.r.o. (HLE)22897Fenistil 1 mg/g gél (gel der 1x50 g (tuba Al))15.9.2024R
 29.10.2024Haleon Czech Republic s.r.o. (HLE)23849Voltaren Rapid 25 mg (cps mol 20x25 mg (blis.PVC/PVDC/Al))25.10.2024O
 29.10.2024Haleon Czech Republic s.r.o. (HLE)34205CALTRATE PLUS (tbl flm 30 (fľ.HDPE))12.6.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)